Ionis Gets FDA Approval for Rare Disease Drug Tryngolza

Published on 20 Dec 2024 on Zacks · via Yahoo Finance

The FDA's nod to IONS' Tryngolza makes it the first approved treatment for FCS. It is also the...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article...

Insider Monkey · via Yahoo Finance 22 Jan 2025

The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease...

Zacks · via Yahoo Finance 20 Jan 2025

This investing style is all about taking advantage of upward or downward trends in a stock's pric...

Zacks · via Yahoo Finance 20 Jan 2025

Today, AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market...

Investing.com 17 Jan 2025

Dividend stocks trading at discounted prices can make for great investments if you're willing to ...

Motley Fool · via Yahoo Finance 15 Jan 2025

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In...

Insider Monkey · via Yahoo Finance 14 Jan 2025

For long-term investors, now may be a good time to reevaluate the contents of your portfolio to s...

Motley Fool · via Yahoo Finance 9 Jan 2025

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 6 Jan 2025

Sweden shares lower at close of trade; OMX Stockholm 30 down 0.28%

Investing.com 31 Dec 2024

Monday, H.C. Wainwright began covering Emergent BioSolutions Inc. (NYSE:EBS) with a Buy rating an...

Investing.com 30 Dec 2024